Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

66.87 USD +1.10 (+1.67%)
Official Closing Price Updated: 7:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,715,800
Open 66.02
Bid (Size) 66.88 (8)
Ask (Size) 66.97 (10)
Prev. Close 65.77
Today's Range 65.86 - 67.09
52wk Range 56.56 - 85.79
Shares Outstanding N/A
Dividend Yield 4.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021
April 15, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2021 financial results will be released on Thursday, April 29, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s... 
From Business Wire News Releases
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer
April 14, 2021
Almost 1/3 of Patients in Pivotal TROPHY Study Responded to Treatment 
From PR Newswire

Performance

YTD
+11.25%
+11.25%
1 Month
+3.80%
+3.80%
3 Month
+5.59%
+5.59%
6 Month
+7.85%
+7.85%
1 Year
-12.63%
-12.63%

More News

Read More
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
April 13, 2021
From Business Wire News Releases
Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metasta
April 08, 2021
From PR Newswire
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
April 08, 2021
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
April 08, 2021
From PR Newswire
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
April 16, 2021
Tags GILD AMGN BCRX
From Benzinga
IBB, AMGN, GILD, ILMN: Large Outflows Detected at ETF
April 14, 2021
Tags ETFs
From ETF Channel
Cancer Biotech Tango Therapeutics Picks Boxer Capital's SPAC To Go Public Via $353M Merger
April 14, 2021
Tags FDA Market News cancer
From Benzinga
Could Vir Biotechnology Be a Millionaire Maker Stock?
Today 6:00 EDT
Tags Market News GILD GSK
From Motley Fool
3 Top Healthcare Stocks to Buy Right Now
April 15, 2021
Tags Market News GILD JNJ
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media